The number of shares and votes in Vimian Group AB (publ) (“Vimian”) increased during November as a result of the share issue of D shares, E1 2025 shares, E2 2025 shares, and E3 2025 shares within the framework of Vimian’s incentive program LTIP 2025/2028. The number of shares increased by a total of 1,762,823 shares, of which 1,067,263 were D shares, 231,847 were E1 2025 shares, 231,855 were E2 2025 shares, and 231,858 were E3 2025 shares.

Today, the last trading day of the month, there are a total of 528,666,200 shares in Vimian. 525,964,554 shares are ordinary shares with one vote per share. 938,823 shares are C shares, 1,067,263 shares are D shares, 231,847 shares are E1 2025 shares, 231,855 shares are E2 2025 shares, and 231,858 shares are E3 2025 shares, each with one-tenth of a vote per share. The total number of votes in Vimian is 526,234,718.6.

For further information, please contact:

Maria Dahllöf Tullberg
Head of IR, Communications & Sustainability
maria.tullberg@vimian.com
+46 73 626 88 86

About Vimian

Vimian is a global animal health company covering four essential and rapidly evolving areas: Specialty Pharma, MedTech, Veterinary Services and Diagnostics. At Vimian, we believe that every animal deserves the best available care. We bring pioneering and entrepreneurial businesses together to make the market’s most innovative offerings accessible to more animal health professionals and pet owners. Headquartered in Stockholm, Sweden, Vimian reaches over 17,000 veterinary clinics and laboratories, sells to over 80 markets, has 1,200 employees and annual revenues of approximately EUR 375 million. For more information, please visit: www.vimian.com.

This information is information that Vimian Group is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2025-11-28 17:30 CET.

Attachments

Change in the number of shares and votes in Vimian

Läs mer på MFN